Raymond James Downgrades Cerence To Market Perform From Outperform As It Falls Short Of Analyst Price Target
- Raymond James analyst Brian Gesuale downgraded Cerence Inc (NASDAQ: CRNC) to Market Perform from Outperform after the share price dropped from the firm's initial $115 price target.
- The current share price was 8.1% above the price target.
- Gesuale is comfortable with FY21 estimates and sees an upside.
- However, expectations for growth above market, connected revenue, and prepaid license revenue estimates in FY22 have shifted from being conservative over the past 12-months to being more reflective or even slightly optimistic of reality, Gesuale's research note stated.
- Cerence will replace Adtalem Global Education Inc (NYSE: ATGE) in the S&P MidCap 400 on July 7 before the market open.
- Price action: CRNC shares traded lower by 4.60% at $118.60 in the market session on the last check Wednesday.
Latest Ratings for CRNC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Goldman Sachs | Downgrades | Buy | Neutral |
| Feb 2022 | Evercore ISI Group | Downgrades | Outperform | In-Line |
| Feb 2022 | Needham | Maintains | Buy |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Brian GesualeNews Downgrades Price Target Small Cap Analyst Ratings Tech Media
